Eunjin Hong

University of Southern California

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Weiqiang Chen

Assistant Professor

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

UNITED STATES

View details

Whitaker Cohn

Associate Director, Multi-Omics Mass Spectrometry Core / Adjunct Assistant Professor of Clinical Pharmacy

University of Southern California

UNITED STATES

View details

Paul Beringer

Professor and Chair

University of Southern California

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eunjin Hong

Research Interests

Explore related searches

Contact this professor

Articles (14)

Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI)

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

Evaluation of Complex Drug Interactions Between Elexacaftor-Tezacaftor-Ivacaftor and Statins Using Physiologically Based Pharmacokinetic Modeling

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation

Pharmacokinetic Enhancement of Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: A Cost Reduction Strategy to Address Global Disparities in Access

Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?

Pharmacokinetics of Omadacycline in Adults with Cystic Fibrosis

Drug-drug interactions involving CFTR modulators: a review of the evidence and clinical implications

Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions between Elexacaftor/Tezacaftor/Ivacaftor and Tacrolimus in Lung Transplant Recipients

Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: mechanistic exploration through physiologically-based pharmacokinetic modeling and a clinical case series.

Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion

Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous Mycobacteria.

Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19.

Zika virus NS3 protease induces bone morphogenetic protein-dependent brain calcification in human fetuses

Collaborators (3)

Weiqiang Chen

Whitaker Cohn

Paul Beringer

Make your next move.